Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04893551 |
| Title | A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | BerGenBio ASA |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NOR | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Samsung Medical Center | Seoul | Korea, Republic of | Details | |||
| Seoul National University Hospital | Seoul | Korea, Republic of | Details | |||
| Yonsei University Health System- Severance Hospital | Seoul | Korea, Republic of | Details | |||
| Haukeland University Hospital Bergen | Bergen | Norway | Details | |||
| National University Hospital | Singapore | Singapore | Details | |||
| Western General Hospital | Edinburgh | United Kingdom | Details | |||
| Guys and St Thomas' NHS Foundation Trust | London | United Kingdom | Details | |||
| Imperial College London, Hammersmith Hospital | London | United Kingdom | Details | |||
| Churchill Hospital | Oxford | United Kingdom | Details |